12/16/2025
Researchers observed that adults prescribed a GLP-1 agent had a 12% higher risk for developing a new chronic cough—one that persists for over 8 weeks— compared with people prescribed another second-line anti-diabetic medication.
To learn more, check out AMA's Morning Rounds newsletter.